ADAMTS8

Chr 11

ADAM metallopeptidase with thrombospondin type 1 motif 8

Also known as: ADAM-TS8, METH2

This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme contains two C-terminal TS motifs, and disrupts angiogenesis in vivo. A number of disorders have been mapped in the vicinity of this gene, most notably lung neoplasms. Reduced expression of this gene has been observed in multiple human cancers and this gene has been proposed as a potential tumor suppressor. [provided by RefSeq, Feb 2016]

OMIMResearchGenerating clinical summary…
0
Active trials
16
Pubs (1 yr)
P/LP submissions
P/LP missense
0.91
LOEUF
Multiple*
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.91LOEUF
pLI 0.000
Z-score 1.97
OE 0.63 (0.450.91)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.52Z-score
OE missense 0.93 (0.871.01)
469 obs / 501.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.63 (0.450.91)
00.351.4
Missense OE?0.93 (0.871.01)
00.61.4
Synonymous OE?1.03
01.21.6
LoF obs/exp: 21 / 33.3Missense obs/exp: 469 / 501.7Syn Z: -0.31

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

ADAMTS8 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →